Monday - December 23, 2024

Chimeric Antigen Receptor-Expressing T Cells as Anti-Cancer Therapeutics

2024-11-26

ALEXANDRIA, Virginia, Nov. 26 -- PURDUE RESEARCH FOUNDATION, West Lafayette, Indiana has been assigned a patent (No. US 12150981 B2, initially filed July 28, 2021) developed by three inventors Philip S. Low, West Lafayette, Indiana; Haiyan Chu, West Lafayette, Indiana; and Yong Gu Lee, West Lafayette, Indiana, for "Chimeric antigen receptor-expressing T cells as anti-cancer therapeutics." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Chimeric Antigen Receptor-Expressing T Cells as Anti-Cancer Therapeutics

Information Request Form

Copyright Targeted News Service 2024